- Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
-
Kim JH, Moon HW, Ko SY, Choe WH, Kwon SY
- KMID: 2069764
- Clin Mol Hepatol.
- 2014 Sep;20(3):274-282.
- doi: 10.3350/cmh.2014.20.3.274
BACKGROUND/AIMS: Quantitation of hepatitis B surface antigen (HBsAg) is an increasingly popular method to determine the treatment response in chronic hepatitis B (CHB) patients. The clinical value of HBsAg level... -
- CITED
-
- Close
- SHARE
-
- Close
